Atomwise
Mark Sabat is an experienced professional in the field of medicinal chemistry, currently serving as the Director of Medicinal Chemistry at Turning Point Therapeutics since January 2022. Prior to this role, Mark held various positions at Takeda, including Associate Director of GI Chemistry and Principal Scientist in Medicinal Chemistry from August 2011 to January 2022, as well as Senior Scientist from August 2006 to June 2011.
This person is not in any offices